ProText Mobility, Inc. (TXTM)

USD 0.0

(-9.09%)

Market Cap (In USD)

1.94 Million

Revenue (In USD)

-

Net Income (In USD)

-54.27 Thousand

Avg. Volume

5.39 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.0031
PE
-
EPS
-
Beta Value
-2.52
ISIN
US74371E2046
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Roger Baylis-Duffield
Employee Count
-
Website
https://www.protxtm.com
Ipo Date
2003-08-19
Details
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.

More Stocks